Eisai
4523.T
₹2,197
Share price
1.74%
Change (1 day)
-34.61%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
P/S ratio for Eisai (4523.T)
P/S ratio as of April 2025 (TTM): 1.41
According to Eisai's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.20. At the end of 2024 the company had a P/S ratio of 2.33.
P/S ratio history for Eisai from 2009 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 2.33 | -14.12% |
| 2023 | 2.71 | -19.33% |
| 2022 | 3.36 | 31.4% |
| 2021 | 2.56 | -16.73% |
| 2020 | 3.07 | -13.71% |
| 2019 | 3.56 | -8.14% |
| 2018 | 3.87 | 20.92% |
| 2017 | 3.20 | -4.43% |
| 2016 | 3.35 | -17.72% |
| 2015 | 4.08 | 90.04% |
| 2014 | 2.14 | 14.97% |
| 2013 | 1.87 | 10.16% |
| 2012 | 1.69 | 20.63% |
| 2011 | 1.40 | 28.22% |
| 2010 | 1.09 | -12.8% |
| 2009 | 1.26 |